Citation: Ar. Hull, THE LEGISLATIVE AND REGULATORY PROCESS IN THE END-STAGE-RENAL-DISEASE(ESRD) PROGRAM, 1973 THROUGH 1997, Seminars in nephrology, 17(3), 1997, pp. 160-169
Citation: Ak. Cheung et Jk. Leypoldt, THE HEMODIALYSIS MEMBRANES - A HISTORICAL-PERSPECTIVE, CURRENT STATE AND FUTURE PROSPECT, Seminars in nephrology, 17(3), 1997, pp. 196-213
Citation: We. Rutherford et R. Gibney, END-STAGE RENAL-DISEASE - A PROVING GROUND FOR QUALITY IMPROVEMENT INHEALTH-CARE, Seminars in nephrology, 17(3), 1997, pp. 218-225
Citation: T. Kapoian et Ra. Sherman, A BRIEF-HISTORY OF VASCULAR ACCESS FOR HEMODIALYSIS - AN UNFINISHED STORY, Seminars in nephrology, 17(3), 1997, pp. 239-245
Citation: Ta. Thornton et Rm. Hakim, MEANINGFUL REHABILITATION OF THE END-STAGE RENAL-DISEASE PATIENT, Seminars in nephrology, 17(3), 1997, pp. 246-252
Citation: K. Sharma et Fn. Ziyadeh, BIOCHEMICAL EVENTS AND CYTOKINE INTERACTIONS LINKING GLUCOSE-METABOLISM TO THE DEVELOPMENT OF DIABETIC NEPHROPATHY, Seminars in nephrology, 17(2), 1997, pp. 80-92
Citation: Me. Molitch, THE RELATIONSHIP BETWEEN GLUCOSE CONTROL AND THE DEVELOPMENT OF DIABETIC NEPHROPATHY IN TYPE-I DIABETES, Seminars in nephrology, 17(2), 1997, pp. 101-113
Citation: Rg. Nelson et al., CLINICAL AND PATHOLOGICAL COURSE OF RENAL-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - THE PIMA INDIAN EXPERIENCE, Seminars in nephrology, 17(2), 1997, pp. 124-131
Citation: Tf. Andoh et al., NEPHROTOXICITY OF IMMUNOSUPPRESSIVE DRUGS - EXPERIMENTAL AND CLINICALOBSERVATIONS, Seminars in nephrology, 17(1), 1997, pp. 34-45